Repositioning Of Central Venous Tube Using Fluoroscopic Guidance
Price Range Across States
What You Might Pay
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
How we estimate these prices
These estimates are based on the RAND Hospital Price Transparency Study (4th Edition, 2024), which found that commercial insurance prices average 224% of Medicare rates nationally. We apply category-specific ratios: Cardiovascular Surgery procedures average 2.24x Medicare rates. Cash/self-pay estimates blend typical cash discounts (55% of billed charges) with Medicare-based estimates (150% of allowed amounts). These are statistical estimates, not quotes. Contact your insurer or provider for actual costs.
Prices by State
| State | Medicare Payment | Billed Charge |
|---|---|---|
| Tennessee | $77.63 | $375.77 |
| Washington | $77.17 | $355.09 |
| Virginia | $76.78 | $354.56 |
| Texas | $73.75 | $700.88 |
| Alabama | $72.09 | $449.50 |
| Indiana | $64.32 | $676.19 |
| New York | $62.34 | $456.65 |
| North Carolina | $62.24 | $618.71 |
| Florida | $61.23 | $704.82 |
| Maryland | $48.84 | $229.03 |
| Massachusetts | $48.52 | $356.73 |
| New Jersey | $46.70 | $355.73 |
| Missouri | $45.79 | $355.19 |
| Illinois | $44.76 | $389.20 |
| Pennsylvania | $44.11 | $270.96 |
| Wisconsin | $40.79 | $616.46 |
| Michigan | $40.56 | $251.39 |
| Colorado | $40.39 | $332.70 |
| Ohio | $40.15 | $426.00 |
| California | $39.92 | $317.81 |
| Nebraska | $39.67 | $258.32 |
| Minnesota | $39.63 | $416.18 |
| Oklahoma | $38.41 | $223.67 |
What the Data Says About Repositioning Of Central Venous Tube Using Fluoroscopic Guidance
Across 23 states with reporting providers, CPT code 36597 (Repositioning Of Central Venous Tube Using Fluoroscopic Guidance) shows a national average Medicare payment of $51.58 against an average billed charge of $401.05. That gap — a 7.8x markup, or 678% above the Medicare allowed amount — reflects chargemaster pricing, not what most insured patients actually pay. Medicare's negotiated rate is the statutory benchmark; commercial insurers typically settle between the two figures based on network contracts.
Cardiovascular Surgery procedures like this one saw 790 services billed to Medicare in 2023 by 638 distinct providers, serving 766 unique beneficiaries. State-level variation is significant: Oklahoma reports the lowest average payment at $38.41, while Tennessee reports the highest at $77.63. Geographic Practice Cost Indices (GPCIs) explain much of that spread — local malpractice premiums, practice expense, and physician work adjustments all shift the allowed amount even when the procedure is identical.
Applying RAND 2024 commercial-to-Medicare ratios specific to the Cardiovascular Surgery category (2.24x), the estimated commercial insurance price lands near $146.45, with self-pay cash discounts commonly bringing the figure closer to $159.32. Uninsured patients facing the full billed charge have the strongest leverage to negotiate — the Hospital Price Transparency Rule (effective January 2021) requires providers to publish standard charges, cash rates, and payer-specific negotiated prices. This data is for educational reference; confirm coverage and out-of-pocket exposure with your insurer before any procedure.
Frequently Asked Questions
How much does Repositioning Of Central Venous Tube Using Fluoroscopic Guidance cost?
The national average Medicare payment for Repositioning Of Central Venous Tube Using Fluoroscopic Guidance (CPT 36597) is $51.58, while providers typically bill $401.05. Prices vary significantly by state, ranging from $38.41 to $77.63.
Why do providers charge more than Medicare pays?
Providers set their own chargemaster rates (billed charges), which are typically much higher than what any insurer pays. Medicare pays a fixed rate based on the procedure code and geographic location. The billed charge is relevant mainly for uninsured patients, who may face prices closer to the submitted charge.
How much does Repositioning Of Central Venous Tube Using Fluoroscopic Guidance cost with insurance?
With commercial insurance, Repositioning Of Central Venous Tube Using Fluoroscopic Guidance costs an estimated $146.45 on average (range: $102.51 – $205.03). Without insurance, the estimated cash price is $159.32. These estimates are based on RAND 2024 research on commercial-to-Medicare price ratios. Your actual cost depends on your insurer, plan, and provider.
Which state has the lowest cost for Repositioning Of Central Venous Tube Using Fluoroscopic Guidance?
Oklahoma has the lowest average Medicare payment for Repositioning Of Central Venous Tube Using Fluoroscopic Guidance at $38.41, while Tennessee has the highest at $77.63. This $39.23 difference reflects geographic variation in healthcare costs, local cost of living, and provider market dynamics.
How many providers perform Repositioning Of Central Venous Tube Using Fluoroscopic Guidance?
Nationally, 638 providers billed Medicare for Repositioning Of Central Venous Tube Using Fluoroscopic Guidance in 2023, performing 790 total services for 766 beneficiaries across 23 states and territories.
What is the billed-to-Medicare markup for Repositioning Of Central Venous Tube Using Fluoroscopic Guidance?
Providers bill 7.8x what Medicare pays for Repositioning Of Central Venous Tube Using Fluoroscopic Guidance — a 678% markup. This gap between billed charges and actual payment is common across healthcare. Uninsured patients may face charges closer to the billed amount, while insured patients pay negotiated rates between the Medicare and billed figures.
Related Guides
Tips to reduce out-of-pocket costs
Your right to upfront pricing
How Medicare payments work
Decode charges and codes
Why bills exceed actual costs
Geographic pricing factors
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.